APO Research
Talk to an analyst

APO RESEARCH · REPORT

Avian Influenza Vaccines

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Selected research

Market Outlook & Growth Opportunities

Global Avian Influenza Vaccines Market Outlook and Growth Opportunities 2026

21 December 2025206 pages

Choose your research edition.

Industry ResearchAvian Influenza Vaccines Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Avian Influenza Vaccines Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Avian Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avian Influenza Vaccines Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Avian Influenza Vaccines Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.

China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

Read the full market overview

In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

This report provides an overview of the global Avian Influenza Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Avian Influenza Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Avian Influenza Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Avian Influenza Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Avian Influenza Vaccines Segment by Company

Merial

QYH Biotech

DHN

HVRI

CEVA

Elanco (Lohmann )

Yebio

Zoetis

FATRO

Kyoto Biken

CAVAC

Ringpu Biology

Vaksindo

ChengDu Tecbond

Sindh Poultry Vaccine Centre

Merck Animal Health

Medion

Avimex Animal Health

JOVAC

Bio-Labs

Avian Influenza Vaccines Segment by Type

H5+H7 Avian Influenza Vaccines

H9 Avian Influenza Vaccines

Avian Influenza Vaccines Segment by Application

Chicken Avian Influenza Vaccines

Duck & Goose Avian Influenza Vaccines

Other

Avian Influenza Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Avian Influenza Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Avian Influenza Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Avian Influenza Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Avian Influenza Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avian Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avian Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avian Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Avian Influenza Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Avian Influenza Vaccines industry.

Chapter 3: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Avian Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Avian Influenza Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Avian Influenza Vaccines Industry Trends Table 2. Avian Influenza Vaccines Industry Drivers Table 3. Avian Influenza Vaccines Industry Opportunities and Challenges Table 4. Avian Influenza Vaccines Industry Restraints Table 5. Global Avian Influenza Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Avian Influenza Vaccines Revenue Share by Company (2021-2026) Table 7. Global Avian Influenza Vaccines Sales Volume by Company (M Doses) & (2021-2026) Table 8. Global Avian Influenza Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Avian Influenza Vaccines Average Price (USD/K Doses) of Company (2021-2026) Table 10. Global Avian Influenza Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Avian Influenza Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Avian Influenza Vaccines Company, Product Type & Application Table 13. Global Avian Influenza Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of H5+H7 Avian Influenza Vaccines Table 18. Significant Companies of H9 Avian Influenza Vaccines Table 19. Global Avian Influenza Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (M Doses) Table 20. Global Avian Influenza Vaccines Sales Volume by Type (2021-2026) & (M Doses) Table 21. Global Avian Influenza Vaccines Sales Volume by Type (2027-2032) & (M Doses) Table 22. Global Avian Influenza Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global Avian Influenza Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global Avian Influenza Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Avian Influenza Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Avian Influenza Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Avian Influenza Vaccines Sales Value Share by Type (2021-2026) Table 28. Global Avian Influenza Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Chicken Avian Influenza Vaccines Table 30. Significant Companies of Duck & Goose Avian Influenza Vaccines Table 31. Significant Companies of Other Table 32. Global Avian Influenza Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (M Doses) Table 33. Global Avian Influenza Vaccines Sales Volume by Application (2021-2026) & (M Doses) Table 34. Global Avian Influenza Vaccines Sales Volume by Application (2027-2032) & (M Doses) Table 35. Global Avian Influenza Vaccines Sales Volume Share by Application (2021-2026) Table 36. Global Avian Influenza Vaccines Sales Volume Share by Application (2027-2032) Table 37. Global Avian Influenza Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Avian Influenza Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Avian Influenza Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Avian Influenza Vaccines Sales Value Share by Application (2021-2026) Table 41. Global Avian Influenza Vaccines Sales Value Share by Application (2027-2032) Table 42. Global Avian Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 43. Global Avian Influenza Vaccines Sales by Region (2021-2026) & (M Doses) Table 44. Global Avian Influenza Vaccines Sales Market Share by Region (2021-2026) Table 45. Global Avian Influenza Vaccines Sales by Region (2027-2032) & (M Doses) Table 46. Global Avian Influenza Vaccines Sales Market Share by Region (2027-2032) Table 47. Global Avian Influenza Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Avian Influenza Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Avian Influenza Vaccines Sales Value Share by Region (2021-2026) Table 50. Global Avian Influenza Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Avian Influenza Vaccines Sales Value Share by Region (2027-2032) Table 52. Global Avian Influenza Vaccines Market Average Price (USD/K Doses) by Region (2021-2026) Table 53. Global Avian Influenza Vaccines Market Average Price (USD/K Doses) by Region (2027-2032) Table 54. Global Avian Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Table 55. Global Avian Influenza Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 57. Global Avian Influenza Vaccines Sales Market Share by Country (2021-2026) Table 58. Global Avian Influenza Vaccines Sales by Country (2027-2032) & (M Doses) Table 59. Global Avian Influenza Vaccines Sales Market Share by Country (2027-2032) Table 60. Global Avian Influenza Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Avian Influenza Vaccines Sales Value Market Share by Country (2021-2026) Table 62. Global Avian Influenza Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Avian Influenza Vaccines Sales Value Market Share by Country (2027-2032) Table 64. Merial Company Information Table 65. Merial Business Overview Table 66. Merial Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 67. Merial Avian Influenza Vaccines Product Portfolio Table 68. Merial Recent Development Table 69. QYH Biotech Company Information Table 70. QYH Biotech Business Overview Table 71. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 72. QYH Biotech Avian Influenza Vaccines Product Portfolio Table 73. QYH Biotech Recent Development Table 74. DHN Company Information Table 75. DHN Business Overview Table 76. DHN Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 77. DHN Avian Influenza Vaccines Product Portfolio Table 78. DHN Recent Development Table 79. HVRI Company Information Table 80. HVRI Business Overview Table 81. HVRI Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 82. HVRI Avian Influenza Vaccines Product Portfolio Table 83. HVRI Recent Development Table 84. CEVA Company Information Table 85. CEVA Business Overview Table 86. CEVA Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 87. CEVA Avian Influenza Vaccines Product Portfolio Table 88. CEVA Recent Development Table 89. Elanco (Lohmann ) Company Information Table 90. Elanco (Lohmann ) Business Overview Table 91. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 92. Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio Table 93. Elanco (Lohmann ) Recent Development Table 94. Yebio Company Information Table 95. Yebio Business Overview Table 96. Yebio Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 97. Yebio Avian Influenza Vaccines Product Portfolio Table 98. Yebio Recent Development Table 99. Zoetis Company Information Table 100. Zoetis Business Overview Table 101. Zoetis Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 102. Zoetis Avian Influenza Vaccines Product Portfolio Table 103. Zoetis Recent Development Table 104. FATRO Company Information Table 105. FATRO Business Overview Table 106. FATRO Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 107. FATRO Avian Influenza Vaccines Product Portfolio Table 108. FATRO Recent Development Table 109. Kyoto Biken Company Information Table 110. Kyoto Biken Business Overview Table 111. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 112. Kyoto Biken Avian Influenza Vaccines Product Portfolio Table 113. Kyoto Biken Recent Development Table 114. CAVAC Company Information Table 115. CAVAC Business Overview Table 116. CAVAC Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 117. CAVAC Avian Influenza Vaccines Product Portfolio Table 118. CAVAC Recent Development Table 119. Ringpu Biology Company Information Table 120. Ringpu Biology Business Overview Table 121. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 122. Ringpu Biology Avian Influenza Vaccines Product Portfolio Table 123. Ringpu Biology Recent Development Table 124. Vaksindo Company Information Table 125. Vaksindo Business Overview Table 126. Vaksindo Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 127. Vaksindo Avian Influenza Vaccines Product Portfolio Table 128. Vaksindo Recent Development Table 129. ChengDu Tecbond Company Information Table 130. ChengDu Tecbond Business Overview Table 131. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 132. ChengDu Tecbond Avian Influenza Vaccines Product Portfolio Table 133. ChengDu Tecbond Recent Development Table 134. Sindh Poultry Vaccine Centre Company Information Table 135. Sindh Poultry Vaccine Centre Business Overview Table 136. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 137. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio Table 138. Sindh Poultry Vaccine Centre Recent Development Table 139. Merck Animal Health Company Information Table 140. Merck Animal Health Business Overview Table 141. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 142. Merck Animal Health Avian Influenza Vaccines Product Portfolio Table 143. Merck Animal Health Recent Development Table 144. Medion Company Information Table 145. Medion Business Overview Table 146. Medion Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 147. Medion Avian Influenza Vaccines Product Portfolio Table 148. Medion Recent Development Table 149. Avimex Animal Health Company Information Table 150. Avimex Animal Health Business Overview Table 151. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 152. Avimex Animal Health Avian Influenza Vaccines Product Portfolio Table 153. Avimex Animal Health Recent Development Table 154. JOVAC Company Information Table 155. JOVAC Business Overview Table 156. JOVAC Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 157. JOVAC Avian Influenza Vaccines Product Portfolio Table 158. JOVAC Recent Development Table 159. Bio-Labs Company Information Table 160. Bio-Labs Business Overview Table 161. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 162. Bio-Labs Avian Influenza Vaccines Product Portfolio Table 163. Bio-Labs Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Avian Influenza Vaccines Distributors List Table 167. Avian Influenza Vaccines Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Avian Influenza Vaccines Product Image Figure 2. Global Avian Influenza Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avian Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Avian Influenza Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Avian Influenza Vaccines Sales Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Avian Influenza Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. H5+H7 Avian Influenza Vaccines Image Figure 10. H9 Avian Influenza Vaccines Image Figure 11. Global Avian Influenza Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 12. Global Avian Influenza Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Avian Influenza Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global Avian Influenza Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Avian Influenza Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Avian Influenza Vaccines Sales Value Share by Type (2021-2032) Figure 17. Chicken Avian Influenza Vaccines Image Figure 18. Duck & Goose Avian Influenza Vaccines Image Figure 19. Other Image Figure 20. Global Avian Influenza Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 21. Global Avian Influenza Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Avian Influenza Vaccines Sales Volume Share by Application (2021-2032) Figure 23. Global Avian Influenza Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Avian Influenza Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Avian Influenza Vaccines Sales Value Share by Application (2021-2032) Figure 26. Global Avian Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 27. Global Avian Influenza Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Avian Influenza Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Avian Influenza Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Avian Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 31. North America Avian Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Avian Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Avian Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Avian Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Avian Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Avian Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. South America Avian Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Avian Influenza Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Avian Influenza Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Avian Influenza Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Avian Influenza Vaccines Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Avian Influenza Vaccines Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • H5+H7 Avian Influenza Vaccines
  • H9 Avian Influenza Vaccines
Applications
  • Chicken Avian Influenza Vaccines
  • Duck & Goose Avian Influenza Vaccines
  • Other
Companies covered
  • Merial
  • QYH Biotech
  • DHN
  • HVRI
  • CEVA
  • Elanco (Lohmann )
  • Yebio
  • Zoetis
  • FATRO
  • Kyoto Biken
  • CAVAC
  • Ringpu Biology
  • Vaksindo
  • ChengDu Tecbond
  • Sindh Poultry Vaccine Centre
  • Merck Animal Health
  • Medion
  • Avimex Animal Health
  • JOVAC
  • Bio-Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Avian Influenza Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Avian Influenza Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Avian Influenza Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Avian Influenza Vaccines Market Dynamics
  1. 2.1 Avian Influenza Vaccines Industry Trends
  2. 2.2 Avian Influenza Vaccines Industry Drivers
  3. 2.3 Avian Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Avian Influenza Vaccines Industry Restraints
3 Avian Influenza Vaccines Market by Company
  1. 3.1 Global Avian Influenza Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Avian Influenza Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Avian Influenza Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Avian Influenza Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Avian Influenza Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Avian Influenza Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Avian Influenza Vaccines Company Product Type and Application
  8. 3.8 Global Avian Influenza Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Avian Influenza Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Avian Influenza Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Avian Influenza Vaccines Market by Type
  1. 4.1 Avian Influenza Vaccines Type Introduction
  2. 4.1.1 H5+H7 Avian Influenza Vaccines
  3. 4.1.2 H9 Avian Influenza Vaccines
  4. 4.2 Global Avian Influenza Vaccines Sales Volume by Type
  5. 4.2.1 Global Avian Influenza Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Avian Influenza Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Avian Influenza Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Avian Influenza Vaccines Sales Value by Type
  9. 4.3.1 Global Avian Influenza Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Avian Influenza Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Avian Influenza Vaccines Sales Value Share by Type (2021-2032)
5 Avian Influenza Vaccines Market by Application
  1. 5.1 Avian Influenza Vaccines Application Introduction
  2. 5.1.1 Chicken Avian Influenza Vaccines
  3. 5.1.2 Duck & Goose Avian Influenza Vaccines
  4. 5.1.3 Other
  5. 5.2 Global Avian Influenza Vaccines Sales Volume by Application
  6. 5.2.1 Global Avian Influenza Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Avian Influenza Vaccines Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Avian Influenza Vaccines Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Avian Influenza Vaccines Sales Value by Application
  10. 5.3.1 Global Avian Influenza Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Avian Influenza Vaccines Sales Value by Application (2021-2032)
  12. 5.3.3 Global Avian Influenza Vaccines Sales Value Share by Application (2021-2032)
6 Avian Influenza Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Avian Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Avian Influenza Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Avian Influenza Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Avian Influenza Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Avian Influenza Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Avian Influenza Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Avian Influenza Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Avian Influenza Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Avian Influenza Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Avian Influenza Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Avian Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Avian Influenza Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Avian Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Avian Influenza Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Avian Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Avian Influenza Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Avian Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Avian Influenza Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Avian Influenza Vaccines Sales Value Share by Country, 2025 VS 2032
7 Avian Influenza Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Avian Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Avian Influenza Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Avian Influenza Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Avian Influenza Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Avian Influenza Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Avian Influenza Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Avian Influenza Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Avian Influenza Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Avian Influenza Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Avian Influenza Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Avian Influenza Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merial
  2. 8.1.1 Merial Company Information
  3. 8.1.2 Merial Business Overview
  4. 8.1.3 Merial Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merial Avian Influenza Vaccines Product Portfolio
  6. 8.1.5 Merial Recent Developments
  7. 8.2 QYH Biotech
  8. 8.2.1 QYH Biotech Company Information
  9. 8.2.2 QYH Biotech Business Overview
  10. 8.2.3 QYH Biotech Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 QYH Biotech Avian Influenza Vaccines Product Portfolio
  12. 8.2.5 QYH Biotech Recent Developments
  13. 8.3 DHN
  14. 8.3.1 DHN Company Information
  15. 8.3.2 DHN Business Overview
  16. 8.3.3 DHN Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 DHN Avian Influenza Vaccines Product Portfolio
  18. 8.3.5 DHN Recent Developments
  19. 8.4 HVRI
  20. 8.4.1 HVRI Company Information
  21. 8.4.2 HVRI Business Overview
  22. 8.4.3 HVRI Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 HVRI Avian Influenza Vaccines Product Portfolio
  24. 8.4.5 HVRI Recent Developments
  25. 8.5 CEVA
  26. 8.5.1 CEVA Company Information
  27. 8.5.2 CEVA Business Overview
  28. 8.5.3 CEVA Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CEVA Avian Influenza Vaccines Product Portfolio
  30. 8.5.5 CEVA Recent Developments
  31. 8.6 Elanco (Lohmann )
  32. 8.6.1 Elanco (Lohmann ) Company Information
  33. 8.6.2 Elanco (Lohmann ) Business Overview
  34. 8.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio
  36. 8.6.5 Elanco (Lohmann ) Recent Developments
  37. 8.7 Yebio
  38. 8.7.1 Yebio Company Information
  39. 8.7.2 Yebio Business Overview
  40. 8.7.3 Yebio Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Yebio Avian Influenza Vaccines Product Portfolio
  42. 8.7.5 Yebio Recent Developments
  43. 8.8 Zoetis
  44. 8.8.1 Zoetis Company Information
  45. 8.8.2 Zoetis Business Overview
  46. 8.8.3 Zoetis Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zoetis Avian Influenza Vaccines Product Portfolio
  48. 8.8.5 Zoetis Recent Developments
  49. 8.9 FATRO
  50. 8.9.1 FATRO Company Information
  51. 8.9.2 FATRO Business Overview
  52. 8.9.3 FATRO Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 FATRO Avian Influenza Vaccines Product Portfolio
  54. 8.9.5 FATRO Recent Developments
  55. 8.10 Kyoto Biken
  56. 8.10.1 Kyoto Biken Company Information
  57. 8.10.2 Kyoto Biken Business Overview
  58. 8.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Kyoto Biken Avian Influenza Vaccines Product Portfolio
  60. 8.10.5 Kyoto Biken Recent Developments
  61. 8.11 CAVAC
  62. 8.11.1 CAVAC Company Information
  63. 8.11.2 CAVAC Business Overview
  64. 8.11.3 CAVAC Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CAVAC Avian Influenza Vaccines Product Portfolio
  66. 8.11.5 CAVAC Recent Developments
  67. 8.12 Ringpu Biology
  68. 8.12.1 Ringpu Biology Company Information
  69. 8.12.2 Ringpu Biology Business Overview
  70. 8.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ringpu Biology Avian Influenza Vaccines Product Portfolio
  72. 8.12.5 Ringpu Biology Recent Developments
  73. 8.13 Vaksindo
  74. 8.13.1 Vaksindo Company Information
  75. 8.13.2 Vaksindo Business Overview
  76. 8.13.3 Vaksindo Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Vaksindo Avian Influenza Vaccines Product Portfolio
  78. 8.13.5 Vaksindo Recent Developments
  79. 8.14 ChengDu Tecbond
  80. 8.14.1 ChengDu Tecbond Company Information
  81. 8.14.2 ChengDu Tecbond Business Overview
  82. 8.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Portfolio
  84. 8.14.5 ChengDu Tecbond Recent Developments
  85. 8.15 Sindh Poultry Vaccine Centre
  86. 8.15.1 Sindh Poultry Vaccine Centre Company Information
  87. 8.15.2 Sindh Poultry Vaccine Centre Business Overview
  88. 8.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio
  90. 8.15.5 Sindh Poultry Vaccine Centre Recent Developments
  91. 8.16 Merck Animal Health
  92. 8.16.1 Merck Animal Health Company Information
  93. 8.16.2 Merck Animal Health Business Overview
  94. 8.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Merck Animal Health Avian Influenza Vaccines Product Portfolio
  96. 8.16.5 Merck Animal Health Recent Developments
  97. 8.17 Medion
  98. 8.17.1 Medion Company Information
  99. 8.17.2 Medion Business Overview
  100. 8.17.3 Medion Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Medion Avian Influenza Vaccines Product Portfolio
  102. 8.17.5 Medion Recent Developments
  103. 8.18 Avimex Animal Health
  104. 8.18.1 Avimex Animal Health Company Information
  105. 8.18.2 Avimex Animal Health Business Overview
  106. 8.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Avimex Animal Health Avian Influenza Vaccines Product Portfolio
  108. 8.18.5 Avimex Animal Health Recent Developments
  109. 8.19 JOVAC
  110. 8.19.1 JOVAC Company Information
  111. 8.19.2 JOVAC Business Overview
  112. 8.19.3 JOVAC Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 JOVAC Avian Influenza Vaccines Product Portfolio
  114. 8.19.5 JOVAC Recent Developments
  115. 8.20 Bio-Labs
  116. 8.20.1 Bio-Labs Company Information
  117. 8.20.2 Bio-Labs Business Overview
  118. 8.20.3 Bio-Labs Avian Influenza Vaccines Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Bio-Labs Avian Influenza Vaccines Product Portfolio
  120. 8.20.5 Bio-Labs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Avian Influenza Vaccines Value Chain Analysis
  2. 9.1.1 Avian Influenza Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Avian Influenza Vaccines Sales Mode & Process
  6. 9.2 Avian Influenza Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Avian Influenza Vaccines Distributors
  9. 9.2.3 Avian Influenza Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst